Journal of Alzheimer s Disease,
Год журнала:
2024,
Номер
unknown, С. 1 - 30
Опубликована: Сен. 11, 2024
Background:
Emerging
evidence
suggests
the
potential
of
hydroxymethylglutaryl-coenzyme
A
(HMG-CoA,
statins)
as
a
therapeutic
option
for
dementia.
Objective:
The
primary
objective
this
study
is
to
assess
current
state
research
on
statins
use
in
dementia,
with
focus
identifying
pivotal
questions
within
field.
Methods:
systemic
search
publications
statin
dementia
between
2007
and
2023
was
conducted,
utilizing
Web
Science
Core
Collection.
scientific
output
analyzed
from
various
perspectives
through
VOSviewer,
CiteSpace,
bibliometrics
website
(https://bibliometric.com/).
Results:
560
articles
authored
by
2,977
individuals
999
institutions
across
58
countries
were
included,
which
published
295
periodicals
cited
21,176
references
16,424
authors.
annual
publication
remained
steady,
while
number
citations
increased
consistently.
U.S.
Mayo
Clinic
emerged
most
significant
country
institution,
respectively.
B.
McGuinness
D.L.
Sparks
eminent
Journal
Alzheimer’s
Disease
influential
journal.
Three
sets
keywords
top
10
identified,
suggesting
Conclusions:
While
show
promising
treatment
their
remains
uncertain
due
reported
short-term
cognitive
impairment
events
questionable
long-term
protective
effects
against
question
ascertain
association
cognition.
mechanisms
underlying
cognition
are
multifaceted.
This
provides
insights
into
status
field
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(2), С. 553 - 553
Опубликована: Янв. 10, 2025
Alzheimer's
disease
(AD)
pathogenesis
is
correlated
with
the
membrane
content
of
various
lipid
species,
including
cholesterol,
whose
interactions
amyloid
precursor
protein
(APP)
have
been
extensively
explored.
Amyloid-β
peptides
triggering
AD
are
products
APP
cleavage
by
secretases,
which
differ
depending
on
and
secretase
location
relative
to
ordered
or
disordered
microdomains.
We
used
high-resolution
NMR
probe
cholesterol
analog
transmembrane
domain
in
two
membrane-mimicking
systems
resembling
perturbed
environments
(bicelles/micelles).
In
bicelles,
spin-labeled
sterol
interacted
peptide
near
amphiphilic
juxtamembrane
region
N-terminal
part
helix,
as
described
earlier
for
cholesterol.
Upon
transition
into
micellar
environment,
another
interaction
site
appeared
where
polar
head
was
buried
hydrophobic
core
hinge
region.
MD
simulations,
moved
between
three
sites,
sliding
along
groove
formed
glycine
residues
composing
dimerization
interfaces
flexible
domain.
Because
environment
modulates
interactions,
role
lipids
defined
state
entire
subsystem
rather
than
effects
individual
species.
Cholesterol
can
interplay
other
(polyunsaturated,
gangliosides,
etc.),
determining
outcome
amyloid-β
production
cascades.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(20), С. 10911 - 10911
Опубликована: Окт. 10, 2024
Alzheimer’s
disease
(AD),
the
most
prevalent
form
of
dementia,
is
expected
to
rise
dramatically
in
incidence
due
global
population
aging.
Traditional
diagnostic
approaches,
such
as
cerebrospinal
fluid
analysis
and
positron
emission
tomography,
are
expensive
invasive,
limiting
their
routine
clinical
use.
Recent
advances
blood-based
biomarkers,
including
amyloid-beta,
phosphorylated
tau,
neurofilament
light,
offer
promising
non-invasive
alternatives
for
early
AD
detection
monitoring.
This
review
synthesizes
current
research
on
these
highlighting
potential
track
pathology
enhance
accuracy.
Furthermore,
this
uniquely
integrates
recent
findings
protein-protein
interaction
networks
microRNA
pathways,
exploring
novel
combinations
proteomic,
genomic,
epigenomic
biomarkers
that
provide
new
insights
into
AD’s
molecular
mechanisms.
Additionally,
we
discuss
integration
with
advanced
neuroimaging
techniques,
emphasizing
revolutionize
diagnostics.
Although
large-scale
validation
still
needed,
represent
a
critical
advancement
toward
more
accessible,
cost-effective,
tools
AD.
Journal of Alzheimer s Disease,
Год журнала:
2024,
Номер
101(s1), С. S371 - S393
Опубликована: Окт. 18, 2024
This
article
examines
the
relationship
between
cholesterol
levels
and
Alzheimer's
disease
(AD),
beginning
with
early
observation
that
individuals
who
died
from
heart
attacks
often
had
brain
amyloid
deposition.
Subsequent
animal
model
research
proved
high
could
hasten
accumulation.
In
contrast,
cholesterol-lowering
treatments
appeared
to
counteract
this
effect.
Human
autopsy
studies
reinforced
cholesterol-AD
connection,
revealing
higher
during
midlife
significantly
correlated
pathology.
effect
was
especially
pronounced
in
aged
40
55.
Epidemiological
data
supported
human
tissue
observations
suggested
managing
reduce
risk
of
developing
AD.
We
analyze
main
observational
clinical
trials
on
efficacy
statins.
While
suggest
a
potential
protective
against
AD,
have
not
consistently
shown
benefit.
The
failure
these
demonstrate
clear
advantage
is
partially
attributed
multiple
factors,
including
timing
statin
therapy,
type
appropriate
selection
patients
for
treatment.
Many
failed
target
might
benefit
most
intervention,
such
as
high-risk
like
APOE4
carriers.
review
addresses
how
implicated
AD
through
various
biological
pathways,
preventive
role
management
by
studies,
difficulties
encountered
trials,
particularly
related
use.
paper
highlights
need
explore
alternate
therapeutic
targets
mechanisms
escape
intervention.
Ageing Research Reviews,
Год журнала:
2024,
Номер
102, С. 102578 - 102578
Опубликована: Ноя. 13, 2024
Alzheimer's
Disease
(AD)
is
the
most
common
form
of
dementia
among
elderly
people.
This
disease
imposes
a
significant
burden
on
healthcare
system,
society,
and
economy
due
to
increasing
global
aging
population.
Current
trials
with
drugs
or
bioactive
compounds
aimed
at
reducing
cerebral
Amyloid
beta
(Aβ)
plaques
tau
protein
neurofibrillary
tangles,
which
are
two
main
hallmarks
this
devastating
neurodegenerative
disease,
have
not
provided
results
in
terms
their
neuropathological
outcomes
nor
met
expected
clinical
end-points.
Ageing,
genetic
environmental
risk
factors,
along
different
symptoms
suggest
that
AD
complex
heterogeneous
disorder
multiple
interconnected
pathological
pathways
rather
than
single
entity.
In
present
review,
we
highlight
discuss
various
non-canonical,
Aβ-independent
mechanisms,
like
gliosis,
unhealthy
dietary
intake,
lipid
sugar
signaling,
cerebrovascular
damage
contribute
onset
development
AD.
We
emphasize
challenging
traditional
"amyloid
cascade
hypothesis"
may
improve
our
understanding
age-related
syndrome
help
fight
progressive
cognitive
decline
Biomolecules,
Год журнала:
2024,
Номер
14(11), С. 1362 - 1362
Опубликована: Окт. 26, 2024
Aging
induces
complex
changes
in
the
lipid
profiles
across
different
areas
of
brain.
These
can
affect
function
brain
cells
and
may
contribute
to
neurodegenerative
diseases
such
as
Alzheimer's
disease.
Research
shows
that
while
overall
profile
human
remains
quite
steady
throughout
adulthood,
specific
occur
with
age,
especially
after
age
50.
include
a
slow
decline
total
content
shifts
composition
fatty
acids,
particularly
glycerophospholipids
cholesterol
levels,
which
vary
depending
on
region.
Lipid
rafts
play
crucial
role
maintaining
membrane
integrity
facilitating
cellular
signaling.
In
context
disease,
have
been
associated
development
For
example,
alterations
raft
lead
increased
accumulation
amyloid
β
(Aβ)
peptides,
contributing
neurotoxic
effects.
droplets
store
neutral
lipids
are
key
for
energy
metabolism.
As
organisms
dynamics
change,
evidence
suggesting
metabolic
activity
over
time.
This
reduced
an
imbalance
synthesis
mobilization,
processes.
model
like
Drosophila,
studies
shown
metabolism
be
influenced
by
diet
insulin
signaling
pathways,
balance.
The
interplay
between
metabolism,
oxidative
stress,
inflammation
is
critical
aging
peroxidation,
consequence
formation
reactive
aldehydes
further
damage
neurons.
Inflammatory
processes
also
disrupt
pathology
AD.
Consequently,
oxidized
integrity,
influencing
pathways
involved
neuronal
survival
function.
Antioxidants and Redox Signaling,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 22, 2024
Lipids,
which
constitute
the
highest
portion
(over
50%)
of
brain
dry
mass,
are
crucial
for
integrity,
energy
homeostasis,
and
signaling
regulation.
Emerging
evidence
revealed
that
lipid
profile
alterations
abnormal
metabolism
occur
during
normal
aging
in
different
forms
neurodegenerative
diseases.
Moreover,
increasing
genome-wide
association
studies
have
validated
new
targets
on
lipid-associated
pathways
involved
disease
development.
Myelin,
protective
sheath
surrounding
axons,
is
efficient
neural
transduction.
As
primary
site
enriched
with
lipids,
impairments
myelin
increasingly
recognized
as
playing
significant
complex
roles
various
diseases,
beyond
simply
being
secondary
effects
neuronal
loss.
Antioxidants,
Год журнала:
2024,
Номер
13(4), С. 435 - 435
Опубликована: Апрель 3, 2024
Down
syndrome
(DS)
is
a
complex
chromosomal
disorder
considered
as
genetically
determined
form
of
Alzheimer’s
disease
(AD).
Maintenance
brain
cholesterol
homeostasis
essential
for
functioning
and
development,
its
dysregulation
associated
with
AD
neuroinflammation
oxidative
damage.
Brain
imbalances
also
likely
occur
in
DS,
concurring
the
precocious
AD-like
neurodegeneration.
In
this
pilot
study,
we
analyzed,
Ts2Cje
(Ts2)
mouse
model
expression
genes
encoding
key
enzymes
involved
metabolism
levels
main
precursors
products
(i.e.,
oxysterols).
The
results
showed,
Ts2
mice
compared
to
euploid
mice,
downregulation
transcription
3-hydroxy-3-methylglutaryl-CoA
reductase
24-dehydrocholesterol
reductase,
latter
originally
recognized
an
indicator
AD,
consequent
reduction
total
levels.
Moreover,
responsible
oxidation
amounts
resulting
oxysterols
were
modified
brains,
autoxidation
increased,
suggesting
exacerbation
cerebral
stress.
We
observed
enhanced
inflammatory
response
underlined
by
upregulation
α-interferon
interleukin-6,
two
cytokines
whose
synthesis
increased
brains
patients.
Overall,
these
suggest
that
DS
share
cycle
derangements
altered
oxysterol
levels,
which
may
contribute
events
both
diseases.